Skip to main content
Premium Trial:

Request an Annual Quote

STMicroelectronics and MobiDiag in Deal to Develop Infectious Disease Detection Biochip

NEW YORK, Oct. 29 (GenomeWeb News) - STMicroelectronics and MobiDiag announced today an agreement to jointly develop a MEMS biochip for genomic-based infectious disease detection.

 

The companies did not disclose the financial terms of the agreement.

 

"The ST/MobiDiag solution will reduce the cost and complexity of the diagnosis by producing consumables that will be very competitive and offer superior performance compared to existing solutions," the companies said in a statement.

 

STMicroelectronics, a Geneva-based, publicly traded semiconductor company, has developed a disposable silicon MEMS chip that uses PCR to perform DNA amplification and detection of DNA sequence. The channels in the silicon act microfluidically to carry the sample and reagents and resistive heating elements control temperature, according to the company.

MobiDiag, of Helsinki, Finland, specializes in biochip-based molecular diagnostics of infectious diseases. The company has developed the ability to analyze and manage microbial genomic data to design panels for clinical diagnosis of microbial pathogens, according to its website.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.